Overview

Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The goal of the pilot study is to compare conventional antibiotic therapy to an aggressive antibiotic therapy plan for the prevention of arrhythmia device infection in high-risk patients undergoing arrhythmia device procedures. All antibiotics are approved for use and readily available.
Phase:
Phase 3
Details
Lead Sponsor:
Population Health Research Institute
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Bacitracin
Cefazolin
Cephalexin